CP and osteoporosis: Overtime, FLS-CP group had higher probability of being prescribed and taking vitamin D and calcium supplementation (87.7% vs 36.9%; OR = 13.6, 95% CI 7.7; 24.3), specific anti-osteoporosis drugs (75.1% vs 8.0%; OR = 56.0, 95% CI 25.5; 122.9), and complete anti-osteoporosis therapy (72.3% vs 5.7%; OR = 87.5, 95% CI 35.0; 218.6) than U-CP.